Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Computational Modeling of Ovarian Cancer: Implications for Therapy and Screening

Shengqing Gu, Stephanie Lheureux, Azin Sayad, Paulina Cybulska, Liat Ben-David Hogen, Iryna Vyarvelska, Dongsheng Tu, Wendy Parulekar, Douglas A. Levine, Marcus Q. Bernardini, Barry Rosen, Amit Oza, Benjamin G. Neel
doi: https://doi.org/10.1101/19009712
Shengqing Gu
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, ON M5G1L7, Canada
7Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Shengqing_gu@dfci.harvard.edu Benjamin.neel@nyumc.org
Stephanie Lheureux
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
3Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON M5G2M9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Azin Sayad
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paulina Cybulska
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
4Division of Gynecologic Oncology, University of Toronto, Toronto, ON M5G2M9, Canada
8Memorial Sloan Kettering Cancer Center, NY 10065, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liat Ben-David Hogen
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
4Division of Gynecologic Oncology, University of Toronto, Toronto, ON M5G2M9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iryna Vyarvelska
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
4Division of Gynecologic Oncology, University of Toronto, Toronto, ON M5G2M9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dongsheng Tu
5NCIC Clinical Trials Group, Queens University, Kingston, ON K7L3N6, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Parulekar
5NCIC Clinical Trials Group, Queens University, Kingston, ON K7L3N6, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas A. Levine
6Laura and Isaac Perlmutter Cancer Center, NYU-Langone Medical Center, NY 10016, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcus Q. Bernardini
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
4Division of Gynecologic Oncology, University of Toronto, Toronto, ON M5G2M9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry Rosen
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
4Division of Gynecologic Oncology, University of Toronto, Toronto, ON M5G2M9, Canada
9Beaumont Hospital, Royal Oak, MI 48073, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit Oza
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
3Division of Medical Oncology and Hematology, University of Toronto, Toronto, ON M5G2M9, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin G. Neel
1Princess Margaret Cancer Center, University Health Network, Toronto, ON M5G2M9, Canada
2Department of Medical Biophysics, University of Toronto, Toronto, ON M5G1L7, Canada
10Laura and Isaac Perlmutter Cancer Center, NYU-Langone Medical Center, NY 10016, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Shengqing_gu@dfci.harvard.edu Benjamin.neel@nyumc.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

High-grade serous ovarian carcinoma (HG-SOC) is a major cause of cancer-related death. Whether treatment order—primary debulking surgery followed by adjuvant chemotherapy (PDS) or neo-adjuvant chemotherapy with interval surgery (NACT)—affects outcome is controversial. We developed a mathematical framework that holds for hierarchical or stochastic models of tumor initiation and reproduces HG-SOC clinical course. After estimating parameter values, we infer that most patients harbor chemo-resistant HG-SOC cells at diagnosis, PDS is inherently superior to NACT due to better depletion of resistant cells, and earlier diagnosis could improve survival of primary, but not relapsed, patients. Our predictions are supported by primary clinical data from multiple cohorts. Our results have clear implications for these key issues in HG-SOC management.

Significance Statement The optimal order and timing of surgery and chemotherapy, and the potential benefits of earlier diagnosis of HG-SOC, remain controversial. We developed a mathematical framework of tumor dynamics to address such issues, populated the model with primary clinical data and reliably recapitulated clinical observations. Our model prospectively predicts that: (1) PDS is inherently superior to NACT; (2) timely adjuvant chemotherapy is critical for the outcome of PDS with <1mm, but not >1mm, residual tumors; (3) earlier detection of relapse is unlikely to be beneficial with current therapies; (4) earlier detection of primary HG-SOC could have substantial benefit. Our model provides insights into the evolutionary dynamics of HG-SOC, argues for new clinical trials to optimize HG-SOC therapy, and is potentially applicable to other tumor types.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by grants from the Terry Fox Foundation (TFPPG 020003), National Cancer Institute (R37 49152), and Department of Defense (60167542 104703 A) (to B.G.N.), and a DCA Award from University of Toronto (to S.G.).

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Yes

Data Availability

All data were acquired from published clinical trials or retrospective studies.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 18, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Computational Modeling of Ovarian Cancer: Implications for Therapy and Screening
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Computational Modeling of Ovarian Cancer: Implications for Therapy and Screening
Shengqing Gu, Stephanie Lheureux, Azin Sayad, Paulina Cybulska, Liat Ben-David Hogen, Iryna Vyarvelska, Dongsheng Tu, Wendy Parulekar, Douglas A. Levine, Marcus Q. Bernardini, Barry Rosen, Amit Oza, Benjamin G. Neel
medRxiv 19009712; doi: https://doi.org/10.1101/19009712
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Computational Modeling of Ovarian Cancer: Implications for Therapy and Screening
Shengqing Gu, Stephanie Lheureux, Azin Sayad, Paulina Cybulska, Liat Ben-David Hogen, Iryna Vyarvelska, Dongsheng Tu, Wendy Parulekar, Douglas A. Levine, Marcus Q. Bernardini, Barry Rosen, Amit Oza, Benjamin G. Neel
medRxiv 19009712; doi: https://doi.org/10.1101/19009712

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (216)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1096)
  • Dentistry and Oral Medicine (196)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (500)
  • Epidemiology (9767)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2308)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1559)
  • Health Policy (735)
  • Health Systems and Quality Improvement (603)
  • Hematology (236)
  • HIV/AIDS (503)
  • Infectious Diseases (except HIV/AIDS) (11641)
  • Intensive Care and Critical Care Medicine (617)
  • Medical Education (237)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2142)
  • Nursing (134)
  • Nutrition (336)
  • Obstetrics and Gynecology (427)
  • Occupational and Environmental Health (517)
  • Oncology (1176)
  • Ophthalmology (364)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (146)
  • Palliative Medicine (50)
  • Pathology (311)
  • Pediatrics (695)
  • Pharmacology and Therapeutics (300)
  • Primary Care Research (267)
  • Psychiatry and Clinical Psychology (2180)
  • Public and Global Health (4657)
  • Radiology and Imaging (778)
  • Rehabilitation Medicine and Physical Therapy (457)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (251)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)